Sponsor or institution

Clinical trials and research at Ruijin Hospital

• 182Clinical trials
• 8New in 30 days
• 1Country

Newest trials

All recruiting trials (newest 150 of 182)

• AI-assisted 4D PET imaging to detect early pancreatic cancer lesions

  This study tests whether AI-assisted 4D long-axial PET imaging with FDG and FAPI can help detect early PDAC lesions in patients with suspected pancreatic tumors.

  Recruiting Ruijin Hospital · Shanghai · NCT07925125

• Urinary Cell-Free DNA Test for Urothelial Cancer Origin

  This study tests a urine-based cell-free DNA test to help diagnose urothelial cancer and identify whether it started in the bladder or upper urinary tract in adults.

  Recruiting Ruijin Hospital · Shanghai · NCT07888374

• Neoadjuvant therapy for locally advanced low rectal cancer: adding fruquintinib to short-course radiotherapy with tislelizumab and CAPOX

  This study tests whether adding fruquintinib to short-course radiotherapy plus tislelizumab and CAPOX before surgery helps people with locally advanced low rectal cancer achieve a better tumor response.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07888309

• Modular Robot-Assisted Esophagectomy vs. Conventional Minimally Invasive Esophagectomy for Esophageal Cancer

  This trial tests whether modular robotic-assisted esophagectomy using the Carina platform works better than conventional 3D thoracoscopic esophagectomy for people with resectable esophageal cancer.

  Recruiting Phase 3 Ruijin Hospital · Shanghai · NCT07888140

• Ivonescimab with pemetrexed and platinum chemotherapy as first-line treatment for advanced malignant pleural mesothelioma

  This study tests whether adding ivonescimab to standard pemetrexed plus platinum-based chemotherapy can help people with newly diagnosed advanced malignant pleural mesothelioma.

  Recruiting at 3 sites Phase 1/2 Ruijin Hospital · Shanghai, Shanghai Municipality and 2 other locations · NCT07885319

• Gecacitinib for patients with myeloid neoplasms and myelofibrosis undergoing allogeneic stem cell transplant

  This study tests whether taking gecacitinib around the time of allogeneic stem cell transplantation is safe and helps engraftment in adults with myeloid neoplasms and myelofibrosis.

  Recruiting Phase 1/2 Ruijin Hospital · Shanghai · NCT07883382

• Sevabertinib in HER2-mutant Advanced NSCLC: Real-world Outcomes

  This study looks at how Sevabertinib works in real-world adults with HER2-mutant advanced NSCLC who have had prior treatment, to see its effectiveness, safety, and impact on quality of life.

  Recruiting Ruijin Hospital · Qionghai, Hainan · NCT07880353

• Longer or shorter ablation duration in renal denervation to lower blood pressure

  In people with resistant hypertension, this study tests whether treating the main renal arteries for 2 minutes per site (vs 1 minute) leads to greater blood pressure reduction.

  Recruiting Ruijin Hospital · Shanghai · NCT07876479

• Fasciotomy and Predilation for Radial Artery Grafts in CABG

  A new way to prepare radial artery grafts during CABG is tested to see if it lowers complications and improves graft durability for adults undergoing this heart surgery.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07868692

• Neoadjuvant immunotherapy plus Nab-P-SOX for locally advanced gastric/GEJ cancer

  This phase 2, single-arm study tests a pre-surgery treatment that combines a PD-1/CTLA-4 bispecific antibody with nab-paclitaxel, oxaliplatin, and S-1 in adults with HER2-negative, locally advanced gastric or GEJ cancer.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07867392

• Inebilizumab for Type 1 Autoimmune Pancreatitis in Adults

  This study tests whether inebilizumab can help adults with type 1 autoimmune pancreatitis by reducing relapses when paired with a standardized steroid taper.

  Recruiting Phase 4 Ruijin Hospital · Shanghai · NCT07862075

• Umbilical Cord Blood CAR-T Cells Targeting CD19 and CD22 for relapsed/refractory B-ALL

  This phase 1 study tests whether dual-target cord blood-derived CAR-T cells against CD19 and CD22 are safe and tolerable in adults with relapsed or refractory B-cell ALL.

  Recruiting Phase 1 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07838714

• Predicting Immunotherapy Response in Advanced Gastric Cancer using PET Imaging

  This study tests whether FAPI PET/CT and Grazytracer PET/CT can predict how advanced gastric cancer will respond to preoperative immunotherapy-based treatment.

  Recruiting Ruijin Hospital · Shanghai · NCT07824479

• Urine test to detect urological cancers in people with blood in urine

  This study tests whether a urine fluorescence test can help find urological cancers in adults with hematuria before biopsy.

  Recruiting Ruijin Hospital · Shanghai · NCT07813260

• Postoperative ctDNA Monitoring to Predict Recurrence in Driver-Mutant Stage I-III Colon Cancer

  This study tests whether checking blood tumor DNA after surgery can predict if driver-mutant stage I-III colon cancer will come back.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07795528

• Chronic Eye graft-versus-host disease: what happens after stem cell transplant

  This study follows people who had a stem cell transplant to see how many develop chronic ocular graft-versus-host disease and how it affects their daily lives.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07794800

• FAPI PET imaging with FAPI-RuiJ and FAPI-04 in solid tumors

  This study tests two FAP-targeted PET tracers (FAPI-RuiJ and FAPI-04) to see which better detects, stages, and monitors solid tumors.

  Recruiting Ruijin Hospital · Shanghai · NCT07776899

• Non-Invasive Nerve Stimulation for Essential Tremor: Long-Term Safety and Effectiveness

  This study tests whether a non-invasive stimulation device called TAPS helps reduce tremor in adults with essential tremor over a long period.

  Recruiting Ruijin Hospital · Shanghai · NCT07774598

• In vivo circular RNA CAR T cell therapy for adults with relapsed or refractory B-cell lymphomas

  A one-arm, dose-escalation study tests a circular RNA CAR T cell therapy in adults with relapsed or refractory CD19-positive B-cell cancers to see if it is safe and tolerable and to get early signs of benefit.

  Recruiting Phase 1 Ruijin Hospital · Shanghai, Shanghai Municipality and 1 other locations · NCT07774572

• STN-tTIS with Different Intervals Compared to Standard Parkinson’s Medicine

  This study tests whether different schedules of subthalamic nucleus-targeted transcranial temporal interference stimulation (STN-tTIS) can better improve motor symptoms in people with Parkinson’s disease than standard medications alone.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07774312

• CCTA-Guided CABG vs CAG-Guided CABG

  This study tests whether planning CABG with a non-invasive CCTA scan works as well as planning with the standard invasive CAG approach for people with blocked heart arteries.

  Recruiting Ruijin Hospital · Shanghai · NCT07769008

• Directional PSA vs STN DBS for tremor-dominant PD

  This study tests whether directional DBS targeting the PSA or the STN helps people with tremor-dominant Parkinson’s disease, using a blinded crossover design.

  Recruiting Ruijin Hospital · Shanghai · NCT07700862

• Managing carotid plaque stability with statins and folic acid

  This study tests whether adding folic acid to statin therapy helps stabilize carotid plaques in adults with plaque who have not had endarterectomy or stenting.

  Recruiting Phase 1/2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07680595

• Personalized cancer vaccine added to adjuvant therapy for solid tumors

  This early-stage study tests ABO2109 combined with toripalimab to see if it is safe and tolerable and to observe how the immune system responds in adults with solid tumors.

  Recruiting Early Phase 1 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07680582

• SEEG-guided DBS for Schizophrenia

  This study tests whether SEEG-guided deep brain stimulation can help people with treatment-resistant schizophrenia see if symptoms improve.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07671261

• Lateral positioning to optimize breathing in adults after abdominal surgery with ARDS

  This study tests whether lying on the left or right side helps improve lung function in adults who developed ARDS after abdominal surgery, using a bedside imaging test to watch ventilation and blood flow while changing positions.

  Recruiting Ruijin Hospital · Shanghai · NCT07669558

• CD45RA-depleted donor cells to help fight stubborn viral infections after haploidentical transplant

  This trial tests whether giving patients specially prepared donor immune cells (CD45RA-depleted DLI) can help clear viral infections that linger after a stem cell transplant and who have not fully recovered their immunity.

  Recruiting Phase 1/2 Ruijin Hospital · Shanghai, SH · NCT07662369

• ES502 dose-escalation study for advanced pancreatic cancer

  A first-in-human test will try ES502 in adults with advanced pancreatic cancer that have few remaining options, to see if it is safe and potentially effective.

  Recruiting Early Phase 1 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07649928

• Reduced-intensity radiotherapy after chemo-induced remission for early-stage nasal NK/T-cell lymphoma

  This study tests whether a lighter course of radiotherapy can keep people in remission after chemotherapy for early-stage nasal-type NK/T-cell lymphoma.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07628738

• BCI with 40Hz Stimulation for Alzheimer’s Disease

  This study tests whether a non-invasive brain-computer interface with 40Hz audio-visual stimulation can improve thinking skills in people with Alzheimer’s disease.

  Recruiting at 2 sites Ruijin Hospital · Shanghai, Shanghai Municipality and 1 other locations · NCT07618481

• Ivosidenib as maintenance therapy for IDH1-mutated AML or high-risk MDS in patients ineligible for transplant

  This study tests whether continuing ivosidenib after induction helps people with IDH1-mutated AML or high-risk MDS who can’t have a transplant, to see if it helps keep cancer from returning.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07607418

• Neoadjuvant Tislelizumab with LM-302 plus S-1 or with SOX for CLDN18.2-positive gastric and gastroesophageal junction adenocarcinoma.

  This trial tests whether giving Tislelizumab together with a CLDN18.2-targeting agent (LM-302) plus S-1 or giving Tislelizumab with oxaliplatin and S-1 before surgery helps people with CLDN18.2-positive, locally advanced gastric or GEJ adenocarcinoma.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Huangpu District · NCT07569068

• LM-302 plus oral S-1 and intraperitoneal paclitaxel, with or without cadonilimab, for Claudin 18.2–positive advanced stomach or GEJ cancer with peritoneal spread

  This trial tests whether adding cadonilimab to LM-302, oral S-1, and intraperitoneal paclitaxel helps people with Claudin 18.2–positive gastric or gastroesophageal junction cancer that has spread to the peritoneum.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Huangpu District · NCT07556640

• Multimodal prospective cohort of Parkinsonism

  This project will try to track disease progression and improve diagnosis using imaging, clinical tests, and biological samples in people with parkinsonism, people with REM sleep behavior disorder, and healthy volunteers over five years.

  Recruiting Ruijin Hospital · Shanghai · NCT07553845

• Sonrotoclax plus azacitidine with targeted agents or chemotherapy for newly diagnosed adult AML

  This trial tests whether adding sonrotoclax to azacitidine, along with targeted drugs or chemotherapy, helps adults newly diagnosed with acute myeloid leukemia.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07548710

• Ultra-hypofractionated regional nodal irradiation for high-risk breast cancer

  A one-week ultra-hypofractionated radiotherapy approach (26 Gy in 5 fractions) is being tested to see if it works as well as the standard three-week regimen (40 Gy in 15 fractions) for patients with high-risk breast cancer who need comprehensive regional nodal irradiation.

  Recruiting Ruijin Hospital · Shanghai · NCT07527689

• Using gut blood flow measurements to predict feeding intolerance in critically ill adults

  This study will test whether bedside ultrasound measurements of gastrointestinal blood flow can help predict which critically ill adults receiving enteral nutrition will develop feeding intolerance.

  Recruiting Ruijin Hospital · Shanghai · NCT07521111

• Pola-ZR-Glo for older patients with large B‑cell lymphoma

  This trial will try combining polatuzumab vedotin, zanubrutinib, lenalidomide, and glofitamab as first-line treatment for people aged 70 and older with newly diagnosed large B‑cell lymphoma who are unfit for standard chemo or decline immunochemotherapy.

  Recruiting Phase 2 Ruijin Hospital · Shanghai · NCT07514169

• Short versus long maribavir treatment after allogeneic stem cell transplant

  This trial tests whether a shorter or longer course of maribavir helps adults with refractory CMV infection after their first allogeneic stem cell transplant.

  Recruiting Phase 3 Ruijin Hospital · Shanghai · NCT07511127

• Sodium bicarbonate, NASOX chemotherapy, and PD-1 immunotherapy delivered directly into the liver for pancreatic cancer metastases.

  This trial tests whether injecting sodium bicarbonate, a NASOX chemotherapy combination, and a PD-1 immune drug directly into the liver can help people whose pancreatic cancer has spread to the liver live longer.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07504471

• Deep inspiration breath-hold planning for internal mammary radiation after breast cancer surgery

  This test will see if different deep inspiration breath-hold settings (1.5–3 mm gating windows) keep the radiation target covered while protecting the heart and lungs for adults getting postoperative radiotherapy that includes the internal mammary nodes.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07498855

• Endovascular stent repair for retrograde ascending aortic dissection

  This trial will try an endovascular stent procedure to repair retrograde ascending aortic dissection in people aged 65 or older who are not suitable for open surgery.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07405242

• SHR-1701 with chemotherapy for gastric/GEJ cancer with peritoneal spread

  This study tests whether SHR-1701 plus either paclitaxel-based therapy with intraperitoneal and intravenous delivery or CAPOX can help adults with gastric or GEJ adenocarcinoma that has spread to the peritoneum.

  Recruiting at 2 sites Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality and 1 other locations · NCT07384234

• PD-1 antibody therapy combined with radiotherapy for early extranodal NK/T‑cell lymphoma

  This trial will try PD‑1 antibody treatment with concurrent radiotherapy, sometimes adding targeted drugs like chidamide or golidocitinib, to see if it helps adults with previously untreated early-stage nasal-type NK/T-cell lymphoma.

  Recruiting Phase 2 Ruijin Hospital · Shanghai · NCT07380984

• AI-driven autonomous registration for robotic bronchoscopy localization

  This trial will test whether an AI system can automatically register and help guide robotic bronchoscopy for adults who need pulmonary nodule localization.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07368829

• Predicting HFNO failure within 72 hours using a physiology-informed model at 30 minutes

  This study tests a model that uses Heart–lung physiology and 30-minute data to see if high-flow nasal oxygen will fail in adults with acute hypoxemic respiratory failure.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07366541

• Comparing oxaliplatin plus S-1 versus docetaxel plus S-1 after surgery for stage III stomach cancer

  This trial tests whether oxaliplatin plus S-1 or docetaxel plus S-1 is better at preventing cancer recurrence in people with stage III gastric cancer after D2 gastrectomy.

  Recruiting Phase 3 Ruijin Hospital · Shaoguan, Guandong and 4 other locations · NCT07366528

• Shanghai clinical cohort for Parkinson's disease and multiple system atrophy (Reserve)

  This project will try to use clinical exams, brain scans, electrical tests, genetic and biosample data from people with Parkinson's disease or multiple system atrophy to find early markers and better subtypes.

  Recruiting Ruijin Hospital · Shanghai · NCT07353463

• Sintilimab plus a bevacizumab biosimilar as adjuvant therapy after surgery for ruptured hepatocellular carcinoma

  This trial will test whether giving sintilimab together with a bevacizumab biosimilar after curative surgery can lower recurrence in adults who had a ruptured hepatocellular carcinoma and complete resection.

  Recruiting at 3 sites Phase 2 Ruijin Hospital · Sanming, Fujian and 3 other locations · NCT07331883

• AI tool to recognize anatomy and find lesions during nasopharyngolaryngoscopy

  This project will try an AI system that reads nasopharyngolaryngoscopy images to help doctors spot anatomy and lesions in adults having these exams.

  Recruiting Ruijin Hospital · Shanghai · NCT07326358

• Wearable sensors to predict DBS results for people with dystonia

  This study will test whether wearable sensors that record walking patterns before surgery can predict how well deep brain stimulation will work for people with dystonia.

  Recruiting Ruijin Hospital · Shanghai · NCT07323602

• RXIM002 for severe, relapsed or refractory B cell–mediated autoimmune diseases

  This trial tests RXIM002, a one-time IV in‑body CD19‑targeting CAR T therapy delivered by circular RNA, in adults 18–65 with severe, relapsed or refractory B cell–mediated autoimmune diseases to see if it is safe and can reduce disease activity.

  Recruiting Early Phase 1 Ruijin Hospital · Shanghai, Huangpu District · NCT07322718

• Cryoablation combined with the dual-function PD-1/CTLA-4 antibody Apalulizumab for locally advanced pancreatic adenocarcinoma after first-line AG failure

  This Phase 2 study will test whether combining tumor cryoablation with the dual-function antibody Apalulizumab helps people with locally advanced pancreatic cancer whose disease progressed after first-line AG chemotherapy.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07306286

• Irreversible electroporation plus a dual PD-1/CTLA-4 antibody for locally advanced pancreatic cancer after first-line AG stops working

  This trial will test whether combining irreversible electroporation with a dual-action PD-1/CTLA-4 antibody (apalulizumab) helps people with locally advanced pancreatic cancer whose disease progressed on first-line AG chemotherapy.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07306273

• Orelabrutinib with lisaftoclax and rituximab for untreated high-risk mantle cell lymphoma

  This trial will try combining orelabrutinib, lisaftoclax, and rituximab in people with untreated, high-risk mantle cell lymphoma to see if it increases complete remissions and delays progression.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07272499

• Cryoablation treatment for pulmonary ground-glass nodules

  This will try cryoablation as a less-invasive treatment for adults with small malignant ground-glass nodules who cannot or choose not to have surgery or radiotherapy.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality and 1 other locations · NCT07232433

• Onradivir tablets for adolescents with uncomplicated influenza A

  This study tests whether Onradivir tablets help 12- to 17-year-olds with uncomplicated influenza A when given for 5 days, compared with a placebo.

  Recruiting Phase 3 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07229547

• Orelabrutinib with rituximab and optional autologous stem cell transplant for mantle cell lymphoma

  This phase 2 trial tests whether adding the oral BTK inhibitor orelabrutinib to rituximab, with optional autologous stem cell transplant and orelabrutinib maintenance, works and is safe for people with newly diagnosed non-high-risk mantle cell lymphoma.

  Recruiting Phase 2 Ruijin Hospital · Shanghai · NCT07199296

• Short-course pelvic radiotherapy followed by CAPOX (capecitabine + oxaliplatin) and bevacizumab, with or without PD‑1 immunotherapy, for locally advanced rectal cancer.

  This trial tests whether adding a PD‑1 immunotherapy to short-course radiotherapy followed by CAPOX and bevacizumab helps adults with locally advanced rectal cancer get a higher complete response rate and fewer distant metastases.

  Recruiting Phase 2 Ruijin Hospital · Shanghai · NCT07198165

• Orelabrutinib and selinexor with methotrexate, thiotepa, or temozolomide for relapsed or refractory CNS lymphoma

  This trial will try adding oral orelabrutinib and selinexor to methotrexate (or thiotepa if MTX can't be used, or temozolomide) to see if it helps people with relapsed or refractory primary or secondary CNS lymphoma.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07191431

• PDR-001 delivered into the brain to remove harmful alpha-synuclein in early Parkinson's

  This trial will try PDR-001 (a peptide packaged in AAV9) injected into a brain target to remove toxic alpha-synuclein in people aged 40–65 with early Parkinson's disease.

  Recruiting Phase 1 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07157345

• Gallium-68 FAPI PET/CT imaging for people with ANCA-associated vasculitis

  This project will test whether Gallium-68 FAPI PET/CT scans can detect lung and kidney involvement in adults with ANCA-associated vasculitis.

  Recruiting Ruijin Hospital · Shanghai · NCT07151521

• HRS-4642 with gemcitabine, albumin-bound paclitaxel and adebrelimab before and after surgery for pancreatic cancer

  This trial tests whether adding HRS-4642 to chemotherapy (gemcitabine plus albumin-bound paclitaxel) and adebrelimab helps people with resectable or borderline resectable pancreatic cancer when given before and after surgery.

  Recruiting Phase 2 Ruijin Hospital · Shanghai · NCT07131514

• Comparing prostate removal with targeted salvage radiotherapy as needed versus prostate removal plus extended pelvic lymph node removal for men with intermediate/high-risk prostate cancer

  This trial tests whether prostate removal followed by targeted salvage radiotherapy when needed works as well and causes fewer complications than prostate removal with extended pelvic lymph node removal in men with intermediate- or high-risk localized prostate cancer and a Briganti nomogram ≥7%.

  Recruiting Ruijin Hospital · Shanghai · NCT07115992

• Low-dose trifluridine/tipiracil plus bevacizumab for metastatic colorectal cancer

  This will try a lower-dose trifluridine/tipiracil plus bevacizumab regimen for people with metastatic colorectal cancer who have progressed after at least two prior treatments.

  Recruiting at 2 sites Phase 2 Ruijin Hospital · Sanming and 1 other locations · NCT07085169

• ctDNA MRD monitoring during neoadjuvant treatment for pancreatic cancer

  We will see if regular blood tests for ctDNA (MRD) during neoadjuvant therapy can predict surgical success and longer survival for adults with borderline resectable or high‑risk resectable pancreatic cancer.

  Recruiting at 2 sites Ruijin Hospital · Shanghai and 1 other locations · NCT07080021

• mRNA therapy that makes a CD19/CD3 T-cell engager (ABO2203) for relapsed or refractory B-cell non-Hodgkin lymphoma.

  This will try an mRNA drug (ABO2203) that makes immune-engaging CD19/CD3 proteins to see if it is safe and helps adults with relapsed or refractory CD19-positive B-cell non-Hodgkin lymphoma.

  Recruiting Phase 1 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07072169

• Personalized mRNA neoantigen vaccine plus anti-PD-1 for gastrointestinal tumors

  This trial will test a personalized mRNA neoantigen vaccine given with sintilimab to see if it helps adults with advanced or high-risk resected gastrointestinal cancers.

  Recruiting Phase 1 Ruijin Hospital · Shanghai, SH · NCT07067385

• PD-1–edited tumor-infiltrating T cells for advanced colorectal cancer

  This test uses a patient's own tumor-infiltrating T cells, edited to remove PD‑1, to see if the treatment is safe and may help adults with advanced colorectal cancer who no longer have standard treatment options.

  Recruiting Phase 1 Ruijin Hospital · Shanghai, None Selected · NCT07035002

• VAM (liposomal mitoxantrone) for secondary AML and myeloid sarcoma

  This trial will test whether VAM (a liposomal form of mitoxantrone) is effective and safe for adults with secondary AML, therapy-related AML, AML with extramedullary disease, or myeloid sarcoma.

  Recruiting Phase 2 Ruijin Hospital · Shanghai · NCT07028086

• Perioperative radiotherapy with SOX chemotherapy plus apatinib and camrelizumab for esophagogastric cancer

  This trial tests whether adding apatinib and camrelizumab to SOX chemotherapy and radiotherapy before and after surgery helps adults with locally advanced gastric or GEJ adenocarcinoma.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07026149

• IBI343 plus sintilimab and chemotherapy for CLDN18.2-positive gastric or gastroesophageal junction cancer

  This trial tests IBI343 combined with sintilimab and standard chemotherapy as a first-line treatment for adults with CLDN18.2-positive, HER2-negative advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.

  Recruiting Phase 1/2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07025889

• Oral microbiota patterns in chronic and autoimmune pancreatitis

  We will sequence mouth bacteria to see if people with chronic pancreatitis or autoimmune pancreatitis have different oral microbiota.

  Recruiting Ruijin Hospital · Shanghai, Shanghai, China · NCT07015580

• FDG and FAPI PET/MR scans to detect vulnerable carotid plaques

  This project will try FDG and FAPI PET/MR scans to see if they can identify active, unstable carotid artery plaques in adults with carotid atherosclerosis to help prevent strokes.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07004673

• MT027 cell injections for advanced peritoneal tumors

  We will try MT027 cell injections in adults with advanced primary or secondary peritoneal tumors to see if they are safe and show early signs of benefit.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07004647

• Comparing drainage options after minimally invasive esophagectomy

  This trial tests three different drainage approaches after minimally invasive esophagectomy to see which leads to less postoperative pain and fewer complications for adults with esophageal cancer.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07004634

• Autologous Basal Layer Stem Cells for Interstitial Lung Disease

  This study tests whether a patient’s own bronchial basal layer stem cells can be safely infused to help people with interstitial lung disease feel better or improve lung function.

  Recruiting at 2 sites Phase 1 Ruijin Hospital · Qionghai, Hainan and 1 other locations · NCT06998706

• Single-dose inhaled RJ026 in people with interstitial lung disease and healthy volunteers.

  This trial will test whether a single inhaled dose of RJ026 is safe and how the body and lungs absorb and clear it in people with interstitial lung disease and in healthy volunteers.

  Recruiting Phase 1 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06992661

• Autologous Basal Layer Stem Cells to Treat Bronchiectasis

  Researchers will test autologous basal layer stem cells delivered through the airways to see if they can safely improve lung tissue in adults with bronchiectasis.

  Recruiting at 2 sites Phase 1 Ruijin Hospital · Qionghai, Hainan and 1 other locations · NCT06987214

• Using genetic information to guide maintenance therapy after stem cell transplantation for blood cancers

  This study is testing whether personalized treatment based on genetic information can help people with blood cancers like acute myeloid leukemia and myelodysplastic syndromes stay healthy after a stem cell transplant.

  Recruiting Phase 2/3 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06972641

• ctDNA MRD-guided adjuvant therapy for resected pancreatic cancer

  This will test whether using circulating tumor DNA (ctDNA) minimal residual disease (MRD) to guide post-surgery chemotherapy helps patients with resected pancreatic ductal adenocarcinoma.

  Recruiting Ruijin Hospital · Shanghai · NCT06966440

• Autologous bronchial basal cell transplant to treat COPD

  This trial tests whether a patient’s own bronchial basal cells, expanded in a lab, can be safely infused into their lungs to improve lung function in COPD.

  Recruiting at 2 sites Phase 1/2 Ruijin Hospital · Qionghai, Hainan and 1 other locations · NCT06946953

• Evaluation of cardiometabolic factors in heart failure patients

  This study looks at how different health factors related to metabolism and body fat affect heart function and outcomes in people with heart failure.

  Recruiting Ruijin Hospital · Shanghai · NCT06939985

• Treatment of relapsed CNS large B-cell lymphoma with Relma-cel and Tislelizumab

  This study is testing a new treatment combining a cellular therapy and an immunotherapy for people with relapsed central nervous system large B-cell lymphoma to see if it helps them feel better and live longer.

  Recruiting Phase 2 Ruijin Hospital · Beijing and 5 other locations · NCT06876688

• Laparoscopic nerve blockade to lower blood pressure in patients with kidney-related diseases

  This study is testing if a special nerve-blocking procedure during kidney surgery can help lower blood pressure in patients with kidney-related diseases.

  Recruiting Ruijin Hospital · Shanghai · NCT06829134

• Comparing two types of radiation therapy for breast cancer

  This study is testing whether a new type of radiation therapy for breast cancer is safer and more effective than the standard treatment to help patients feel better and live longer.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06826885

• Using AI to Diagnose Solid Pancreatic Lesions

  This study is testing a new AI system to see if it can help doctors better and faster diagnose solid pancreatic lesions during an ultrasound procedure.

  Recruiting at 2 sites Ruijin Hospital · Shanghai, Shanghai Municipality and 1 other locations · NCT06824909

• Robot-assisted dye marking for lung nodule surgery

  This study tests if using a robot to help mark lung nodules before surgery works better than the usual method for people with lung nodules found on CT scans.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06821451

• Transfemoral VitaFlow Liberty treatment for pure aortic regurgitation

  This trial will test whether replacing the aortic valve through the leg with the VitaFlow Liberty valve plus usual medical care helps people aged 60 and older with moderate-to-severe or worse isolated aortic regurgitation.

  Recruiting at 4 sites Phase 4 Ruijin Hospital · Shanghai, Shanghai Municipality and 3 other locations · NCT06818084

• Polatuzumab plus R‑CHP with a genotype‑guided targeted drug for untreated DLBCL

  This test will see if adding a genotype‑guided targeted drug to polatuzumab plus R‑CHP helps adults in China with untreated diffuse large B‑cell lymphoma who show limited early ctDNA response.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06803693

• Observing the progression of bicuspid aortic valve in Chinese patients

  This study looks at how bicuspid aortic valve affects young Chinese patients over time to better understand the condition and improve treatment options.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06802016

• Using 68Ga-FAPI PET/CT to find thyroid cancer recurrence after surgery

  This study is testing if a special type of scan can help find thyroid cancer that has come back after surgery in patients who are at risk for recurrence.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06800768

• Using rTMS guided by MEG to treat migraines

  This study is testing whether a new treatment using brain stimulation can help people with migraines feel better compared to a standard medication.

  Recruiting Ruijin Hospital · Shanghai · NCT06796725

• New methods for evaluating lymphoma treatment response using PET/CT imaging

  This study is testing a new way to see how well lymphoma treatments are working by looking at PET/CT scans from 4,000 patients to help doctors make better decisions about care.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06795113

• Evaluating plaque progression in coronary artery disease using advanced imaging techniques

  This study is testing how advanced imaging can help us understand the growth of plaque in the arteries of people with coronary artery disease over five years and how different factors and treatments affect their heart health.

  Recruiting at 2 sites Ruijin Hospital · Shanghai and 1 other locations · NCT06794684

• Identifying biomarkers for high-risk coronary plaques

  This study is trying to find new blood markers that can help predict dangerous heart plaque in patients with chronic heart issues or certain types of heart attacks.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06793787

• Evaluating coronary artery plaque using advanced imaging techniques

  This study is testing new imaging techniques to better understand coronary artery plaque in patients with heart conditions and see if these methods can help predict serious heart problems in the future.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06793774

• MZL-IPI–guided targeted therapy for untreated marginal zone lymphoma

  This trial will try different targeted drug combinations based on MZL-IPI risk to treat adults newly diagnosed with marginal zone lymphoma who need systemic therapy.

  Recruiting at 3 sites Phase 2 Ruijin Hospital · Shanghai, China and 2 other locations · NCT06793189

• Evaluating tucidinostat for treating newly diagnosed DLBCL patients

  This study is testing if a new drug called tucidinostat can help newly diagnosed patients with diffuse large B-cell lymphoma feel better and stay safe, comparing results between those who can and can't handle standard chemotherapy.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06779435

• Using 68Ga-grazytracer PET/CT to assess response to immunotherapy in lung cancer

  This study is testing if a special type of imaging can help doctors see how well immunotherapy is working for patients with lung cancer before they have surgery.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06756217

• Using PET imaging to predict immunotherapy success in lymphoma patients

  This study is testing if PET scans can help predict how well immunotherapy works for patients with diffuse large B-cell lymphoma.

  Recruiting Ruijin Hospital · Shanghai · NCT06755775

• Comparing two deep brain stimulation techniques for treating dystonic tremor

  This study is testing which deep brain stimulation technique works better for treating dystonic tremor by comparing two different brain areas in patients who have the condition.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06752434

• Evaluating Belimumab's effect on antibody levels in patients with Antiphospholipid Syndrome

  This study is testing if adding Belimumab to standard treatment can lower antibody levels in people with Antiphospholipid Syndrome.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06747312

• mRNA (ABO2203) that delivers a CD19/CD3 T‑cell engager for people with refractory autoimmune diseases

  This trial will test whether an mRNA injection called ABO2203, which produces a CD19/CD3 T‑cell engager, is safe and helpful for adults whose autoimmune disease did not respond to standard treatments.

  Recruiting at 2 sites Early Phase 1 Ruijin Hospital · Wuhan, Hubei and 2 other locations · NCT06747156

• Evaluating 68Ga-FAPI PET/CT for treating advanced liver cancer

  This study is testing if a special type of imaging can help doctors see how well treatment is working for people with advanced liver cancer.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06746194

• Evaluating 68Ga-FAPI PET/CT for Thyroid Cancer with Lymph Node Metastases

  This study is testing a new type of imaging called 68Ga-FAPI PET/CT to see if it helps doctors better assess thyroid cancer in patients with lymph node spread before surgery.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06730529

• Treatment for MRD-Positive B-ALL Patients Using CAR-T Therapy

  This study is testing a new CAR-T therapy to see if it can help adults with a specific type of leukemia who still have some cancer cells left after their first treatment.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06718244

• A new AI-based imaging solution for children with suspected tumors

  This study is testing a new, quieter imaging method using AI to see if it can make it easier and safer for kids suspected of having tumors to get the scans they need.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06709690

• Study on outcomes of patients undergoing stem cell transplantation

  This study looks at the experiences and outcomes of patients who have had or are about to have stem cell transplants to see how their treatment and health changes over time.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality and 2 other locations · NCT06708130

• New treatment for previously untreated diffuse large B-cell lymphoma

  This study tests a new combination treatment for people with newly diagnosed double-expression lymphoma to see if it works better based on their genetic makeup.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06701357

• Comparing immunotherapy bridging treatment to standard therapy in low-risk B-NHL patients

  This study is testing whether adding an immunotherapy treatment with zanubrutinib helps people with low-risk B-cell non-Hodgkin lymphoma feel better compared to those who don’t get this extra treatment.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06695013

• Evaluating Uterine Blood Stem Cells for Severe Viral Pneumonia Treatment

  This study is testing if injections of stem cells from menstrual blood can help people with severe viral pneumonia feel better when combined with standard treatments.

  Recruiting Phase 1 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06693362

• Evaluating telitacicept for treating IgA nephropathy

  This study is testing if a new treatment called telitacicept can help people with IgA nephropathy who are at high risk of their condition getting worse.

  Recruiting Ruijin Hospital · Shanghai · NCT06654596

• Using 68Ga-grazytracer PET to monitor immunotherapy responses in advanced soft tissue sarcomas

  This study is testing if a special type of imaging can help doctors see how well immunotherapy is working for people with advanced soft tissue sarcomas.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06644287

• Using 68Ga-grazytracer PET to monitor immunotherapy responses in gastrointestinal cancers

  This study is testing if a special type of PET scan can help doctors see how well immunotherapy is working for people with gastrointestinal cancers.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06644274

• Investigating respiratory viruses and immunity in healthy individuals in Shanghai

  This study is trying to understand the variety of respiratory viruses in healthy young adults in Shanghai and how factors like age and gender affect their immune responses.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06641856

• Using 68Ga-grazytracer PET imaging to evaluate immunotherapy in lung cancer

  This study is testing if a special type of PET imaging can help doctors see how well immunotherapy is working for patients with stage III non-small cell lung cancer.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06623487

• Evaluating PET/CT Imaging for Advanced Colorectal Cancer

  This study is testing if two types of PET/CT imaging can help doctors see how well conversion therapy is working for patients with advanced colorectal cancer and peritoneal metastasis.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06601075

• Using 68Ga-grazytracer PET to monitor immunotherapy responses in pancreatic cancer

  This study is testing if a special type of PET scan can help doctors see how well immunotherapy is working for people with pancreatic cancer.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06601010

• Using 68Ga-grazytracer PET to monitor immunotherapy responses in liver cancer

  This study is testing if a special type of imaging can help doctors see how well immunotherapy is working for people with advanced liver cancer after a few treatment cycles.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06597539

• Evaluating PET/CT Imaging for Gastric Cancer Treatment Assessment

  This study is testing if special PET/CT scans can help doctors see how well conversion therapy is working for people with advanced gastric cancer that has spread to the lining of the abdomen.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06597526

• Lymphocyte-sparing radiotherapy for esophageal cancer

  This study is testing a new type of radiation therapy for people with advanced esophageal cancer to see if it can protect their immune cells and improve their chances of survival.

  Recruiting Ruijin Hospital · Shanghai, China · NCT06596954

• HRS-4642 with gemcitabine and albumin-bound paclitaxel as pre- and post-surgery treatment for pancreatic cancer

  This trial will test whether adding HRS-4642 to gemcitabine and albumin-bound paclitaxel helps people with resectable or borderline resectable pancreatic ductal adenocarcinoma when given before and after surgery.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06587061

• KRAS neoantigen mRNA vaccine for patients with KRAS-mutated solid tumors

  This study is testing a new mRNA vaccine for patients with advanced solid tumors that have KRAS mutations to see if it can help them when used alone or with another treatment.

  Recruiting Early Phase 1 Ruijin Hospital · Shanghai · NCT06577532

• De-escalation radiation strategy for advanced head and neck cancer

  This study is testing a new treatment plan for people with advanced head and neck cancer to see if combining immunotherapy with chemotherapy before radiation can help them avoid more intense surgery later on.

  Recruiting Phase 1/2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06572514

• Treatment for breast cancer that has spread to the liver using a new ablation technique

  This study is testing a new treatment method for breast cancer that has spread to the liver to see if it works better than the standard approach.

  Recruiting Ruijin Hospital · Shanghai · NCT06567353

• New approach for managing jaundice before pancreatic cancer surgery

  This study is testing a new way to manage jaundice in patients with pancreatic cancer before surgery to see if using a different blood test can lead to better outcomes and fewer complications.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06541340

• Collecting data on cellular immunotherapy for lymphoma patients

  This study is gathering information from adults with relapsed or hard-to-treat non-Hodgkin's lymphoma who are getting cellular immunotherapy to see how well it works and how safe it is.

  Recruiting Ruijin Hospital · Shanghai · NCT06541327

• Exploring imaging techniques for diagnosing degenerative dementia

  This study is trying to see if new imaging techniques can help doctors better diagnose and understand different types of dementia, including Alzheimer's, by tracking patients over time.

  Recruiting at 8 sites Ruijin Hospital · Beijing, Beijing Municipality and 7 other locations · NCT06534658

• Evaluating surgical options for lung cancer patients after initial treatment

  This study is testing if switching from a major lung surgery to a smaller one is safe and helpful for lung cancer patients who have already received treatment.

  Recruiting Ruijin Hospital · Shanghai · NCT06534489

• Registry of Chinese Patients with Marginal Zone Lymphoma

  This study looks at how Chinese patients with marginal zone lymphoma are treated in real life to see how well those treatments work and how they affect patients' quality of life.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06534463

• Comparing Pola-ZR2 and ZR2 for treating elderly patients with diffuse large B-cell lymphoma

  This study is testing if adding a new drug called polatuzumab vedotin to a standard treatment helps older patients with diffuse large B-cell lymphoma feel better and improve their outcomes.

  Recruiting Phase 3 Ruijin Hospital · Shanghai · NCT06522555

• Treatment for advanced gastric cancer with peritoneal metastasis using a combination of therapies

  This study is testing a new combination of treatments for people with advanced gastric cancer that has spread to the abdomen to see if it can help slow down the disease and improve their health.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Huangpu District · NCT06519591

• mRNA vaccine and PD-1 inhibitor for pancreatic cancer treatment

  This study is testing a personalized mRNA vaccine combined with a PD-1 inhibitor to see if it can help people with resectable pancreatic cancer who can’t tolerate chemotherapy after their surgery.

  Recruiting Early Phase 1 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06496373

• Combining Orelabrutinib with Bendamustine and Rituximab for treating Mantle Cell Lymphoma

  This study is testing if adding Orelabrutinib to the standard treatment of Bendamustine and Rituximab can help people with intermediate- to high-risk mantle cell lymphoma who can't have a transplant feel better and live longer.

  Recruiting Phase 3 Ruijin Hospital · Shanghai · NCT06496308

• Treatment for relapsed Hodgkin's and Anaplastic Large Cell Lymphoma using LCAR-HL30

  This study is testing a new treatment called LCAR-HL30 to see if it can help adults with relapsed Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma feel better.

  Recruiting Phase 1 Ruijin Hospital · Shanghai · NCT06494371

• Combining immunotherapy with chemotherapy for esophagogastric junction cancer treatment

  This study is testing if combining a new immunotherapy drug with standard chemotherapy can help people with operable esophagogastric junction cancer feel better and improve their treatment outcomes.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06482788

• Evaluating treatments for high-risk recurrence of Type 1 Autoimmune Pancreatitis

  This study tests if using glucocorticoids alone or with another medication can help prevent the return of Type 1 Autoimmune Pancreatitis in patients who are at high risk for it.

  Recruiting Phase 4 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06468709

• Allogeneic stem cell transplantation for high-relapse-risk CEBPA mutant acute myeloid leukemia

  This study is testing whether a stem cell transplant can help people with a specific type of acute myeloid leukemia that has a high chance of coming back after treatment.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06458257

• Evaluating stem cell transplantation for high-risk acute myeloid leukemia

  This study is testing if stem cell transplantation after chemotherapy can help people with high-risk acute myeloid leukemia live longer and stay free of the disease.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06458244

• Boosting radiation treatment for high-risk breast cancer patients

  This study is testing if adding extra radiation treatment to a specific area can help high-risk breast cancer patients live longer after their initial therapy.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06404697

• Pre-surgery chemotherapy followed by immunotherapy for locally advanced colon cancer

  This trial will see if giving CAPEOX chemotherapy before surgery and then adding the immunotherapy serplulimab helps adults with locally advanced, MSS/RAS-mutant colon cancer get better tumor responses and live longer.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06368141

• CAR-T therapy after stem cell transplant for relapsed B-cell lymphoma

  This study is testing if a new CAR-T therapy can help people with relapsed B-cell lymphoma feel better after they’ve had a stem cell transplant.

  Recruiting Phase 2 Ruijin Hospital · Shanghai · NCT06365671

• Organ preservation strategies for esophageal cancer treatment

  This study is testing a new treatment approach that combines chemotherapy, radiation, and immunotherapy to see if it can help people with advanced esophageal cancer avoid surgery and improve their quality of life.

  Recruiting Phase 3 Ruijin Hospital · Shanghai · NCT06339060

• Evaluating a new treatment for recurrent adult acute myeloid leukemia and myelodysplastic syndrome

  This study is testing a new combination treatment for adults with recurrent acute myeloid leukemia and myelodysplastic syndrome to see if it works better than current options.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06329999

• Pegylated interferon treatment for chronic hepatitis B patients who previously received interferon

  This study is testing if a new pegylated interferon treatment can help people with chronic hepatitis B who didn't get better with previous interferon therapy.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06323681

• Using Toripalimab before surgery for advanced lung cancer with specific mutations

  This study is testing if giving a new immunotherapy called Toripalimab before surgery can help people with advanced lung cancer who have specific genetic mutations feel better and improve their chances of recovery.

  Recruiting at 2 sites Phase 2 Ruijin Hospital · Guangzhou, Guangdong and 1 other locations · NCT06269211

• Combining Toripalimab with Chemoradiotherapy for Cervical Cancer

  This study is testing if adding an immunotherapy drug called toripalimab to standard treatment can help women with newly diagnosed locally advanced cervical cancer do better than with just the standard treatment alone.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06256224

• Feasibility of advanced stereotactic radiotherapy for brain metastases

  This study is testing a new type of precise radiation treatment for patients with brain metastases to see if it can control tumors better and improve their quality of life compared to standard methods.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06231186

• Assessing risk factors and outcomes in patients with coronary chronic total occlusion

  This study looks at how different treatments for coronary chronic total occlusion affect the long-term health of patients and what factors might influence their recovery.

  Recruiting Ruijin Hospital · Shanghai · NCT06137521

Showing recruiting studies first, then the newest. Describe your situation to find the ones that fit you.

Quick answers

How many clinical trials run by Ruijin Hospital are recruiting right now?

182, as of November 12, 2026. 8 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 40, Phase 1: 12, Phase 3: 10, Phase 1/2: 8. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →